Wall St. Watchdog reveals information about insiders who are bearish on these stocks in the Healthcare sector for the week ending November 25th, 2011.
- Jacques Tapiero who is SVP&Pres., Emerging Markets at Eli Lilly & Co. (NYSE:LLY), sold 5,000 shares on Nov 18 at $36.88 per share for a total value of $184,400. The shares recently traded at $36.27, down $0.62, or 1.68% since the insider sale. About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products. Get the most recent company news and stock data here >>
- Ronda E Stryker who is Director at Stryker Corp. (NYSE:SYK), sold 9,000 shares on Nov 18 at $48.10 per share for a total value of $432,927. The shares recently traded at $46.96, down $0.85, or 1.78% since the insider sale. About the company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Get the most recent company news and stock data here >>
- Robert Hagemann who is SVP & Chief Financial Officer at Quest Diagnostics Inc. (NYSE:DGX), sold 4,150 shares on Nov 21 at $54.40 per share for a total value of $225,760. The shares recently traded at $56.09, up $1.47, or 2.69% since the insider sale. About the company: Quest Diagnostics Incorporated provides diagnostic testing, information, and services. The Company operates a national network of full-service laboratories, rapid response laboratories, and patient service centers. Quest Diagnostics provides esoteric testing, routine medical testing, drugs of abuse testing, and non-hospital-based anatomicpathology testing. Get the most recent company news and stock data here >>
(Note: Selected financial data are sourced from publicly available SEC filings. All data are assumed to be accurate.)
Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>